Compare CBAN & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CBAN | EOLS |
|---|---|---|
| Founded | 1975 | 2012 |
| Country | United States | United States |
| Employees | 506 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 423.6M | 454.4M |
| IPO Year | 1995 | 2018 |
| Metric | CBAN | EOLS |
|---|---|---|
| Price | $20.08 | $6.53 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $15.50 |
| AVG Volume (30 Days) | 369.5K | ★ 766.3K |
| Earning Date | 04-22-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.44% | N/A |
| EPS Growth | ★ 16.91 | 1.23 |
| EPS | ★ 0.39 | N/A |
| Revenue | N/A | ★ $297,176,000.00 |
| Revenue This Year | $35.41 | $13.27 |
| Revenue Next Year | $4.84 | $17.62 |
| P/E Ratio | $51.33 | ★ N/A |
| Revenue Growth | N/A | ★ 11.61 |
| 52 Week Low | $15.80 | $3.86 |
| 52 Week High | $21.61 | $10.20 |
| Indicator | CBAN | EOLS |
|---|---|---|
| Relative Strength Index (RSI) | 47.84 | 45.06 |
| Support Level | $19.20 | $6.44 |
| Resistance Level | $20.40 | $6.95 |
| Average True Range (ATR) | 0.51 | 0.32 |
| MACD | -0.09 | -0.06 |
| Stochastic Oscillator | 26.98 | 13.59 |
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.